Adverum BiotechnologiesADVM
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 57 institutions reported holding Adverum Biotechnologies Inc. (ADVM) in their 13F filings, down 12 from Q1 2025. 18 opened new positions and 29 sold out. The largest holders were BML Capital Management, LLC ($6.6M), Principia Wealth Advisory, LLC ($4.4M) and TCG Crossover Management, LLC ($3.9M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Adverum Biotechnologies Inc.
- CUSIP
- 00773U207
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $1.7M |
| Exits | 29 | $9.4M |
All 13F filers, Q1 2025 → Q2 2025: 1,932,079 shares bought and 4,098,817 shares sold, net −2,166,738 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 57 holders
| BML Capital Management, LLC | 5.04% | Add +11.5% | 3,057,526 | $6.6M |
| Principia Wealth Advisory, LLC | 3.71% | Add +19.6% | 2,029,116 | $4.4M |
| TCG Crossover Management, LLC | 0.44% | No change | 1,796,482 | $3.9M |
| Frazier Life Sciences Management, L.P. | 0.09% | No change | 1,069,244 | $2.3M |
| Vanguard Group Inc. | 0.00% | Reduce -14.1% | 883,937 | $1.9M |
| Renaissance Technologies | 0.00% | Add +257.6% | 570,669 | $1.2M |
| 5AM Venture Management, LLC | 0.45% | No change | 541,666 | $1.2M |
| Goldman Sachs Group Inc. | 0.00% | Add +7.9% | 497,287 | $1.1M |
| BlackRock, Inc. | 0.00% | Reduce -71.0% | 414,485 | $891K |
| Pale Fire Capital SE | 0.08% | Reduce -2.6% | 358,724 | $771K |
| Millennium Management | 0.00% | New | 342,340 | $736K |
| Soleus Capital Management, L.P. | 0.04% | No change | 287,246 | $618K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -0.6% | 286,050 | $615K |
| Geode Capital Management, LLC | 0.00% | Reduce -59.1% | 184,762 | $397K |
| Regeneron Pharmaceuticals, Inc. | 0.03% | No change | 180,909 | $389K |
| Waverly Advisors, LLC | 0.00% | Add +0.3% | 160,578 | $345K |
| Citadel Advisors | 0.00% | New | 78,271 | $168K |
| Jane Street Group, LLC | 0.00% | New | 70,931 | $153K |
| State Street Corp. | 0.00% | Reduce -81.1% | 68,824 | $148K |
| Readystate Asset Management LP | 0.01% | New | 67,602 | $145K |
| Susquehanna International Group, LLP | 0.00% | Add +58.6% | 59,211 | $127K |
| Morgan Stanley | 0.00% | Reduce -23.0% | 52,937 | $114K |
| Marshall Wace, LLP | 0.00% | New | 49,628 | $107K |
| Quinn Opportunity Partners LLC | 0.01% | No change | 41,418 | $89K |
| Bank of America Corp. | 0.00% | Reduce -19.4% | 41,266 | $89K |
| Northern Trust Corp. | 0.00% | Reduce -77.1% | 34,391 | $74K |
| Qube Research & Technologies Ltd | 0.00% | New | 30,679 | $66K |
| HRT Financial LP | 0.00% | New | 30,627 | $65K |
| XTX Topco Ltd | 0.00% | New | 29,755 | $64K |
| D. E. Shaw & Co. | 0.00% | Reduce -0.7% | 26,752 | $58K |
| Jain Global LLC | 0.00% | New | 21,819 | $47K |
| Squarepoint Ops LLC | 0.00% | New | 21,652 | $47K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 21,122 | $45K |
| Two Sigma Investments, LP | 0.00% | New | 18,757 | $40K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 14,582 | $31K |
| UBS Group AG | 0.00% | Reduce -75.4% | 14,170 | $30K |
| Two Sigma Advisers, LP | 0.00% | New | 10,681 | $23K |
| American Century Companies Inc. | 0.00% | Reduce -39.5% | 10,670 | $23K |
| Captrust Financial Advisors | 0.00% | Reduce -5.9% | 10,000 | $22K |
| Royal Bank of Canada | 0.00% | Add +8.5% | 2,769 | $6K |
| Cwm, LLC | 0.00% | Add +21.1% | 2,153 | $5K |
| FMR LLC | 0.00% | Reduce -82.8% | 2,324 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -11.0% | 2,137 | $5K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 1,916 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +1064.8% | 1,689 | $4K |
| Jones Financial Companies LLLP | 0.00% | New | 1,000 | $2K |
| Raymond James Financial Inc. | 0.00% | New | 1,000 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -52.3% | 786 | $2K |
| Point72 (DIFC) Ltd | 0.00% | New | 225 | $484 |
| Wells Fargo & Company | 0.00% | Reduce -98.3% | 214 | $461 |
| Eq Wealth Advisors, LLC | 0.00% | No change | 162 | $348 |
| Allworth Financial LP | 0.00% | No change | 102 | $220 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -68.4% | 84 | $181 |
| SBI Securities Co., Ltd. | 0.00% | No change | 84 | $181 |
| Parallel Advisors, LLC | 0.00% | No change | 50 | $108 |
| GHP Investment Advisors, Inc. | 0.00% | No change | 20 | $43 |
| Deutsche Bank AG | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is ADVM's weight in each manager's 13F, not the share of Adverum Biotechnologies Inc. the manager owns.